Prediction of Multi peptides Vaccination from VP10,VP21, VP51 against Reverse Transcriptase Human immunodeficiency Viruses Using Immuno-informatics Approach
Idris, S. A. A.; Mohamed, I. I.; Siddig, H. A. e.; Abd albagi, S. o.; Khalil Abuzeid, N. M.
Show abstract
The human immunodeficiency virus-(HIV) is group of the genus Lentivirus within the family of Retroviridae, subfamily Ortho retrovirinae. Based on genetic characteristics and differences in the viral antigens, HIV is classified into the types 1 and 2 (HIV-1, HIV-2). HIV is identical single - stranded RNA molecule that are enclosed within the core of the virus particle proteins, the genome of the HIV Provirus, also known as DNA, is generated by the Protease against reverse transcriptase RNA genome into DNA, degradation of the RNA and integration of the double - stranded HIV DNA into the human genome. The aim of this study is to determine antigenic peptides from p10, p21, and p51 proteins that can be used for multiple peptide vaccine design using In-Silico study. A total of 73 sequences of three proteins were obtained from NCBI and subjected to multiple sequence alignments using CLUSTALW tool to determine conserved regions. Immune Epitope Data Base tools were used to determine B cell epitopes, these tools are Bepipred Linear B cell epitopes prediction, surface accessibility and antigenicity prediction. Epitope binding to MHC class I and class II and their population coverage were also determined using IEDB software. The analysis results are as follow, for B cell binding from p10 (708QGYSP712), from p21 (704QGYSP708, 73CVPTDPNPQ81) and (346"FKNL349) from p51. All these peptides have high score in Linear B cell epitopes prediction, surface accessibility and antigenicity prediction. On another hand peptides that reacted to MHC class I were (47EANTTLFCA55, 53FCASDAKAY61, 55,ASDAKAYET63) form p10,(38YYGVPVWKE46, 10PQEVFLVNV18 and 29AAGSTMGAA37) from p21 and (63"EWEFVNTPP71, 70PPLVKLWYQ78 and 79EKEPIVGA87) from p51 protein respectively. It worth noting that the peptides (119IISLWDQSL127, 108CVKLTPLCV116) from p10, (38YYGVPVWKE46, 20LLQYWSQEL34, 16FNMWKNNMV30) from p21 and (7WKGSPAIFQ21, 11WEFVNTPPL25 and 58 FLWMGYELH72) protein is also binds to MHC class II with high affinity. All T cell peptides had highest population coverage, and the combined coverage for all peptides in this study was found to be 100%. Using In-Silico studies will ensure less risk of virulence and side effects. Evaluation of antibodies response in animal models is needed to confirm efficacy of these epitopes in inducing protective immune response.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches 97%
- Immuno-informatics Design of a Multimeric Epitope Peptide Based Vaccine Targeting SARS-CoV-2 Spike Glycoprotein 96%
- iBRAB: in silico based-designed Broad-spectrum Fab against H1N1 Influenza A Virus 96%
Similar papers in this journal
- Epitope-Based Peptide Vaccine against Bombali Ebolavirus Viral Protein 40: An Immunoinformatics Combined with Molecular Docking Studies 98%
- Zika viral proteome analysis reveals an epitope cluster within NS3 helicase as a potential vaccine candidate: an in silico study 98%
- A Multiple Peptides Vaccine against nCOVID-19 Designed from the Nucleocapsid phosphoprotein (N) and Spike Glycoprotein (S) via the Immunoinformatics Approach 97%
Similar papers in this journal
- Epitope-based peptide vaccine against glycoprotein G of Nipah henipavirus using immunoinformatics approaches 98%
- Design of Epitope Based Peptide Vaccine Against Pseudomonas Aeruginosa Fructose Bisphosphate Aldolase Protein using Immunoinformatics 98%
- Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In silico analysis 97%
Similar papers in this journal
- Contriving a chimeric polyvalent vaccine to prevent infections caused by Herpes Simplex Virus (Type-1 and Type-2): an exploratory immunoinformatic approach 97%
- Molecular Basis for Reduced Cleavage Activity and Drug Resistance in D30N HIV-1 protease 96%
- SARS-CoV-2 mutations and where to find them: An in silico perspective of structural changes and antigenicity of the Spike protein 95%
Similar papers in this journal
- Analyses of spike protein from first deposited sequences of SARS-CoV2 from West Bengal, India 96%
- Glibenclamide, ATP and Metformin Increases the Expression of Human Bile Salt Export Pump ABCB11 94%
- Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.